$208 Million is the total value of Ghost Tree Capital, LLC's 59 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 112.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | New | GILEAD SCIENCES INCcall | $11,783,000 | – | 125,000 | +100.0% | 5.65% | – |
| ZBH | Buy | ZIMMER HLDGS INC | $9,777,000 | +94.5% | 86,200 | +72.4% | 4.69% | +71.9% |
| SYK | New | STRYKER CORPcall | $9,433,000 | – | 100,000 | +100.0% | 4.53% | – |
| ISIS | New | ISIS PHARMACEUTICALS INCcall | $9,261,000 | – | 150,000 | +100.0% | 4.44% | – |
| AAVL | Buy | AVALANCHE BIOTECHNOLOGIES IN | $6,750,000 | +294.7% | 125,000 | +150.0% | 3.24% | +249.0% |
| T107PS | New | WRIGHT MED GROUP INC | $6,314,000 | – | 235,000 | +100.0% | 3.03% | – |
| GILD | New | GILEAD SCIENCES INC | $6,127,000 | – | 65,000 | +100.0% | 2.94% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $5,678,000 | +375.9% | 30,000 | +500.0% | 2.72% | +320.5% |
| FLML | New | FLAMEL TECHNOLOGIES SAsponsored adr | $5,567,000 | – | 325,000 | +100.0% | 2.67% | – |
| CPHD | New | CEPHEID | $5,414,000 | – | 100,000 | +100.0% | 2.60% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $5,335,000 | +95.1% | 55,000 | +57.1% | 2.56% | +72.5% |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $5,278,000 | – | 286,053 | +100.0% | 2.53% | – |
| DEPO | Buy | DEPOMED INC | $4,833,000 | +165.1% | 300,000 | +150.0% | 2.32% | +134.5% |
| DYAX | New | DYAX CORP | $4,570,000 | – | 325,000 | +100.0% | 2.19% | – |
| B108PS | Buy | ACTAVIS PLC | $4,505,000 | +24.5% | 17,500 | +16.7% | 2.16% | +10.1% |
| ZLTQ | Sell | ZELTIQ AESTHETICS INC | $4,466,000 | +12.8% | 160,000 | -8.6% | 2.14% | -0.3% |
| NVRO | New | NEVRO CORP | $4,447,000 | – | 115,000 | +100.0% | 2.13% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $4,400,000 | +99.9% | 85,000 | +70.0% | 2.11% | +76.7% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $4,248,000 | +46.1% | 150,000 | +30.4% | 2.04% | +29.2% |
| NUVA | Buy | NUVASIVE INC | $4,244,000 | +143.3% | 90,000 | +80.0% | 2.04% | +115.0% |
| INSYQ | New | INSYS THERAPEUTICS INC NEW | $4,216,000 | – | 100,000 | +100.0% | 2.02% | – |
| HZNP | Sell | HORIZON PHARMA PLC | $3,867,000 | -25.9% | 300,000 | -29.4% | 1.86% | -34.5% |
| AIRM | New | AIR METHODS CORP | $3,743,000 | – | 85,000 | +100.0% | 1.80% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,616,000 | – | 40,000 | +100.0% | 1.74% | – |
| KITE | New | KITE PHARMA INC | $3,460,000 | – | 60,000 | +100.0% | 1.66% | – |
| SLXP | New | SALIX PHARMACEUTICALS INC | $3,448,000 | – | 30,000 | +100.0% | 1.65% | – |
| AMAG | New | AMAG PHARMACEUTICALS INC | $3,410,000 | – | 80,000 | +100.0% | 1.64% | – |
| ADXS | New | ADVAXIS INC | $3,389,000 | – | 423,100 | +100.0% | 1.63% | – |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $3,338,000 | – | 30,000 | +100.0% | 1.60% | – |
| SYK | New | STRYKER CORP | $3,302,000 | – | 35,000 | +100.0% | 1.58% | – |
| ISIS | New | ISIS PHARMACEUTICALS INCput | $3,087,000 | – | 50,000 | +100.0% | 1.48% | – |
| OPHT | New | OPHTHOTECH CORP | $2,917,000 | – | 65,000 | +100.0% | 1.40% | – |
| QDEL | QUIDEL CORP | $2,892,000 | +7.6% | 100,000 | 0.0% | 1.39% | -4.8% | |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $2,862,000 | -12.7% | 20,000 | -20.0% | 1.37% | -22.9% |
| TXMD | Sell | THERAPEUTICSMD INC | $2,834,000 | -18.6% | 636,800 | -15.1% | 1.36% | -28.0% |
| BLUE | Sell | BLUEBIRD BIO INC | $2,752,000 | +119.1% | 30,000 | -14.3% | 1.32% | +93.7% |
| FOLD | New | AMICUS THERAPEUTICS INC | $2,496,000 | – | 300,000 | +100.0% | 1.20% | – |
| ARAY | New | ACCURAY INC | $2,265,000 | – | 300,000 | +100.0% | 1.09% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $2,170,000 | – | 80,000 | +100.0% | 1.04% | – |
| ISRG | Sell | INTUITIVE SURGICAL INC | $2,116,000 | -46.1% | 4,000 | -52.9% | 1.02% | -52.3% |
| BDSI | New | BIODELIVERY SCIENCES INTL IN | $2,104,000 | – | 175,000 | +100.0% | 1.01% | – |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $2,061,000 | -45.5% | 300,000 | -57.1% | 0.99% | -51.8% |
| ATRC | Sell | ATRICURE INC | $1,996,000 | -45.8% | 100,000 | -60.0% | 0.96% | -52.0% |
| ACHN | New | ACHILLION PHARMACEUTICALS INcall | $1,838,000 | – | 150,000 | +100.0% | 0.88% | – |
| New | IMMUNOGEN INC | $1,830,000 | – | 300,000 | +100.0% | 0.88% | – | |
| BLCM | New | BELLICUM PHARMACEUTICALS INC | $1,728,000 | – | 75,000 | +100.0% | 0.83% | – |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $1,578,000 | – | 150,000 | +100.0% | 0.76% | – |
| MMSI | New | MERIT MED SYS INC | $1,300,000 | – | 75,000 | +100.0% | 0.62% | – |
| TNDM | Sell | TANDEM DIABETES CARE INC | $1,270,000 | -28.0% | 100,000 | -24.0% | 0.61% | -36.4% |
| NSTG | NANOSTRING TECHNOLOGIES INC | $1,254,000 | +27.3% | 90,000 | 0.0% | 0.60% | +12.5% | |
| SNN | Buy | SMITH & NEPHEW PLCspdn adr new | $1,102,000 | -12.7% | 30,000 | +100.0% | 0.53% | -22.9% |
| ASPX | New | AUSPEX PHARMACEUTICALS INC | $1,050,000 | – | 20,000 | +100.0% | 0.50% | – |
| WMGIZ | Buy | WRIGHT MED GROUP INCright 03/01/2019 | $884,000 | +206.9% | 185,000 | +38.1% | 0.42% | +171.8% |
| OCRX | OCERA THERAPEUTICS INC | $796,000 | +29.9% | 125,000 | 0.0% | 0.38% | +14.7% | |
| BIOL | BIOLASE INC | $789,000 | +5.6% | 300,000 | 0.0% | 0.38% | -6.4% | |
| CLDN | New | CELLADON CORP | $781,000 | – | 40,000 | +100.0% | 0.38% | – |
| CPRX | New | CATALYST PHARM PARTNERS INC | $743,000 | – | 250,000 | +100.0% | 0.36% | – |
| ASMB | ASSEMBLY BIOSCIENCES INC | $511,000 | -3.9% | 65,000 | 0.0% | 0.24% | -15.2% | |
| GBIM | New | GLOBEIMMUNE INC | $178,000 | – | 23,500 | +100.0% | 0.08% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -200,000 | -100.0% | -0.12% | – |
| FLXN | Exit | FLEXION THERAPEUTICS INC | $0 | – | -12,488 | -100.0% | -0.12% | – |
| Exit | CATALYST PHARM PARTNERS INCput | $0 | – | -100,000 | -100.0% | -0.18% | – | |
| UNIS | Exit | UNILIFE CORP NEW | $0 | – | -150,000 | -100.0% | -0.19% | – |
| PSDV | Exit | PSIVIDA CORP | $0 | – | -100,000 | -100.0% | -0.24% | – |
| LPCN | Exit | LIPOCINE INC NEW | $0 | – | -91,768 | -100.0% | -0.30% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.32% | – |
| RCPT | Exit | RECEPTOS INC | $0 | – | -12,300 | -100.0% | -0.42% | – |
| Exit | ALCOBRA LTDcall | $0 | – | -50,000 | -100.0% | -0.42% | – | |
| Exit | VANDA PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.56% | – | |
| ALIM | Exit | ALIMERA SCIENCES INCput | $0 | – | -200,000 | -100.0% | -0.59% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.67% | – |
| ONTY | Exit | ONCOTHYREON INC | $0 | – | -700,000 | -100.0% | -0.73% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -35,000 | -100.0% | -0.75% | – |
| ZFGN | Exit | ZAFGEN INC | $0 | – | -75,000 | -100.0% | -0.80% | – |
| Exit | ACHILLION PHARMACEUTICALS INcall | $0 | – | -150,000 | -100.0% | -0.81% | – | |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -100,000 | -100.0% | -0.85% | – |
| MDT | Exit | MEDTRONIC INC | $0 | – | -30,000 | -100.0% | -1.01% | – |
| AEGR | Exit | AEGERION PHARMACEUTICALS INC | $0 | – | -60,000 | -100.0% | -1.09% | – |
| ATRS | Exit | ANTARES PHARMA INC | $0 | – | -1,100,000 | -100.0% | -1.09% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -80,500 | -100.0% | -1.21% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -125,000 | -100.0% | -1.32% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -25,000 | -100.0% | -1.39% | – |
| BRKR | Exit | BRUKER CORP | $0 | – | -140,000 | -100.0% | -1.41% | – |
| SPNC | Exit | SPECTRANETICS CORP | $0 | – | -100,000 | -100.0% | -1.44% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -35,000 | -100.0% | -1.54% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -65,000 | -100.0% | -1.60% | – |
| Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -200,000 | -100.0% | -1.70% | – | |
| ZSPH | Exit | ZS PHARMA INC | $0 | – | -85,000 | -100.0% | -1.81% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS IN | $0 | – | -100,000 | -100.0% | -1.88% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -280,966 | -100.0% | -1.92% | – |
| Exit | ACCURAY INCnote 3.750% 8/0 | $0 | – | -500,000 | -100.0% | -1.97% | – | |
| THOR | Exit | THORATEC CORP | $0 | – | -140,000 | -100.0% | -2.03% | – |
| CYBX | Exit | CYBERONICS INC | $0 | – | -75,000 | -100.0% | -2.08% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -45,000 | -100.0% | -2.20% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -60,000 | -100.0% | -2.30% | – |
| Exit | CEPHEIDcall | $0 | – | -100,000 | -100.0% | -2.39% | – | |
| AGN | Exit | ALLERGAN INC | $0 | – | -25,000 | -100.0% | -2.42% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -2.44% | – |
| TRNX | Exit | TORNIER N V | $0 | – | -200,000 | -100.0% | -2.59% | – |
| CYH | Exit | COMMUNITY HEALTH SYS INC NEW | $0 | – | -100,000 | -100.0% | -2.97% | – |
| Exit | AGILENT TECHNOLOGIES INCcall | $0 | – | -100,000 | -100.0% | -3.09% | – | |
| Exit | ABBVIE INCcall | $0 | – | -100,000 | -100.0% | -3.14% | – | |
| Exit | VALEANT PHARMACEUTICALS INTLcall | $0 | – | -50,000 | -100.0% | -3.56% | – | |
| Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -200,000 | -100.0% | -5.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2015-02-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.